Shares of Arkema SA (OTCMKTS:ARKAY – Get Free Report) have been given an average rating of “Reduce” by the eight research firms that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and one has assigned a buy recommendation to the company.
Several research firms have recently issued reports on ARKAY. The Goldman Sachs Group lowered Arkema from a “buy” rating to a “neutral” rating in a research note on Monday, June 8th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Arkema in a research report on Tuesday, June 23rd. Berenberg Bank lowered Arkema from a “strong-buy” rating to a “hold” rating in a report on Monday, April 20th. Zacks Research upgraded Arkema from a “strong sell” rating to a “hold” rating in a research report on Monday, May 4th. Finally, Kepler Capital Markets lowered shares of Arkema from a “hold” rating to a “strong sell” rating in a research note on Thursday, May 7th.
Get Our Latest Stock Analysis on Arkema
Arkema Stock Up 0.9%
Arkema (OTCMKTS:ARKAY – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The basic materials company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.91 by $0.10. Arkema had a return on equity of 4.06% and a net margin of 0.46%.The company had revenue of $2.57 billion during the quarter, compared to analyst estimates of $2.52 billion. On average, equities research analysts anticipate that Arkema will post 3.48 EPS for the current fiscal year.
About Arkema
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Recommended Stories
- Five stocks we like better than Arkema
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
